These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6499354)

  • 1. Effect of metoclopramide on digoxin absorption from tablets and capsules.
    Johnson BF; Bustrack JA; Urbach DR; Hull JH; Marwaha R
    Clin Pharmacol Ther; 1984 Dec; 36(6):724-30. PubMed ID: 6499354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of digoxin capsules and tablets: effect of coadministered fluid volume.
    Bustrack JA; Katz JD; Hull JH; Foster JR; Hammond JE; Christenson RH
    J Pharm Sci; 1984 Oct; 73(10):1397-400. PubMed ID: 6502488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes.
    Heizer WD; Pittman AW; Hammond JE; Fitch DD; Bustrack JA; Hull JH
    DICP; 1989 Oct; 23(10):764-9. PubMed ID: 2815851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide.
    Johnson BF; O'Grady J; Bye C
    Br J Clin Pharmacol; 1978 May; 5(5):465-7. PubMed ID: 656287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of magnesium--aluminum hydroxide and kaolin--pectin on absorption of digoxin from tablets and capsules.
    Allen MD; Greenblatt DJ; Harmatz JS; Smith TW
    J Clin Pharmacol; 1981 Jan; 21(1):26-30. PubMed ID: 7012189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cisapride and metoclopramide on digoxin bioavailability.
    Kirch W; Janisch HD; Santos SR; Duhrsen U; Dylewicz P; Ohnhaus EE
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):249-50. PubMed ID: 3582418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.
    Brown DD; Schmid J; Long RA; Hull JH
    J Clin Pharmacol; 1985; 25(5):360-4. PubMed ID: 4031112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J; Johnson BF; Bye C; French J
    Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased digoxin cardioinactive-reduced metabolites after administration as an encapsulated liquid concentrate.
    Rund DG; Lindenbaum J; Dobkin JF; Butler VP; Saha JR
    Clin Pharmacol Ther; 1983 Dec; 34(6):738-43. PubMed ID: 6641088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute bioavailability of digoxin tablets.
    Beveridge T; Nüesch E; Ohnhaus EE
    Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater bioavailability of digoxin solution in capsules. Studies in the postprandial state.
    Lindenbaum J
    Clin Pharmacol Ther; 1977 Mar; 21(3):278-82. PubMed ID: 576419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of soft gelatin on digoxin absorption.
    O'Grady J; Johnson BF; Bye C; Sabey GA
    Br J Clin Pharmacol; 1978 May; 5(5):461-3. PubMed ID: 656286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
    Bjornsson TD; Huang AT; Roth P; Jacob DS; Christenson R
    Clin Pharmacol Ther; 1986 Jan; 39(1):25-8. PubMed ID: 3943266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF; Smith G; French J
    Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intersubject variation in absorption of digoxin in normal volunteers.
    Huffman DH; Manion CV; Azarnoff DL
    J Pharm Sci; 1975 Mar; 64(3):433-7. PubMed ID: 1151628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients.
    Astorri E; Bianchi G; La Canna G; Assanelli D; Visioli O; Marzo A
    J Pharm Sci; 1979 Jan; 68(1):104-6. PubMed ID: 364006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.